Medri L - Search Results

1

An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and on 116 recurrences.

Zoli W, Volpi A, Bonaguri C, Riccobon A, Savini S, Brizio R, Saragoni A, Medri L, Marra GA, Amadori D. Zoli W, et al. Among authors: medri l. Breast Cancer Res Treat. 1991 Jan-Feb;17(3):231-8. doi: 10.1007/BF01806372. Breast Cancer Res Treat. 1991. PMID: 2039842

2

c-kit and SCF expression in normal and tumor breast tissue.

Ulivi P, Zoli W, Medri L, Amadori D, Saragoni L, Barbanti F, Calistri D, Silvestrini R. Ulivi P, et al. Among authors: medri l. Breast Cancer Res Treat. 2004 Jan;83(1):33-42. doi: 10.1023/B:BREA.0000010694.35023.9e. Breast Cancer Res Treat. 2004. PMID: 14997053

3

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.

Ridolfi R, Flamini E, Riccobon A, De Paola F, Maltoni R, Gardini A, Ridolfi L, Medri L, Poletti G, Amadori D. Ridolfi R, et al. Among authors: medri l. Cancer Immunol Immunother. 1998 Jun;46(4):185-93. doi: 10.1007/s002620050477. Cancer Immunol Immunother. 1998. PMID: 9671141 Free PMC article.

4

Tumor microvessel density and prognosis in node-negative breast cancer.

Medri L, Nanni O, Volpi A, Scarpi E, Dubini A, Riccobon A, Becciolini A, Bianchi S, Amadori D. Medri L, et al. Int J Cancer. 2000 Jan 20;89(1):74-80. Int J Cancer. 2000. PMID: 10719734

5

Vascular endothelial growth factor and prognosis in patients with node-negative breast cancer.

De Paola F, Granato AM, Scarpi E, Monti F, Medri L, Bianchi S, Amadori D, Volpi A. De Paola F, et al. Among authors: medri l. Int J Cancer. 2002 Mar 10;98(2):228-33. doi: 10.1002/ijc.10118. Int J Cancer. 2002. PMID: 11857413

6

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Among authors: medri l. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

7

[Epidermoid cyst of the spleen. Presentation of a case].

Gaudio M, Brizio R, Medri L, Marra GA, Padovani F, Vio A, Saragoni A. Gaudio M, et al. Among authors: medri l. Pathologica. 1990 Jul-Aug;82(1080):465-70. Pathologica. 1990. PMID: 2284149 Italian.

8

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

De Paola F, Ridolfi R, Riccobon A, Flamini E, Barzanti F, Granato AM, Mordenti GL, Medri L, Vitali P, Amadori D. De Paola F, et al. Among authors: medri l. Br J Cancer. 2003 Jan 27;88(2):320-6. doi: 10.1038/sj.bjc.6600679. Br J Cancer. 2003. PMID: 12610520 Free PMC article.

9

[Peripheral T-cell lymphoma associated with hemophagocytic syndrome: a recently identified entity. Clinico-pathologic and immunohistochemical study of 2 cases].

Saragoni A, Falini B, Medri L, Gaudio M, Brizio R, Poggi S, Sabattini E, Pileri S. Saragoni A, et al. Among authors: medri l. Pathologica. 1990 Jul-Aug;82(1080):359-69. Pathologica. 1990. PMID: 2284138 Italian.

10

Comparison between different cell kinetic variables in human breast cancer.

Barzanti F, Dal Susino M, Volpi A, Amadori D, Riccobon A, Scarpi E, Medri L, Bernardi L, Naldi S, Aldi M, Gaudio M, Zoli W. Barzanti F, et al. Among authors: medri l. Cell Prolif. 2000 Apr;33(2):75-89. doi: 10.1046/j.1365-2184.2000.00165.x. Cell Prolif. 2000. PMID: 10845252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters